BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26615223)

  • 1. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
    Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
    Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
    Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
    J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
    Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
    Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of pro-adrenomedullin in early diagnosis of sepsis].
    Yan L; Cailan L; Hong L; Zheng L; Wei D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):739-42. PubMed ID: 26955700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
    Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
    Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
    Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
    J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
    Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
    J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ventilator bundle treatment of acute respiratory distress syndrome and its correlation with biomarkers of inflammation].
    Yang J; Dong C; Li J; Zhang H; Zhang H; Song R; Yang Z; Feng F; Qi Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):544-8. PubMed ID: 25124901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome.
    Yilmaz G; Köksal I; Karahan SC; Mentese A
    Clin Biochem; 2011 Oct; 44(14-15):1227-30. PubMed ID: 21816136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
    Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
    Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. suPAR as a prognostic biomarker in sepsis.
    Donadello K; Scolletta S; Covajes C; Vincent JL
    BMC Med; 2012 Jan; 10():2. PubMed ID: 22221662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in plasma interleukin-33 concentration in sepsis and its correlation with seriousness of sepsis].
    Chang D; Jia J; Zang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):138-42. PubMed ID: 25665614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocan is useful biomarker of survival and severity in sepsis.
    Mihajlovic DM; Lendak DF; Brkic SV; Draskovic BG; Mitic GP; Novakov Mikic AS; Cebovic TN
    Microvasc Res; 2014 May; 93():92-7. PubMed ID: 24769132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
    Giamarellos-Bourboulis EJ; Norrby-Teglund A; Mylona V; Savva A; Tsangaris I; Dimopoulou I; Mouktaroudi M; Raftogiannis M; Georgitsi M; Linnér A; Adamis G; Antonopoulou A; Apostolidou E; Chrisofos M; Katsenos C; Koutelidakis I; Kotzampassi K; Koratzanis G; Koupetori M; Kritselis I; Lymberopoulou K; Mandragos K; Marioli A; Sundén-Cullberg J; Mega A; Prekates A; Routsi C; Gogos C; Treutiger CJ; Armaganidis A; Dimopoulos G
    Crit Care; 2012 Aug; 16(4):R149. PubMed ID: 22873681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
    Ma J; Wang S; Chen D; Duan J; Li C; Li G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The correlation between procalcitonin, C-reactive protein and severity scores in patients with sepsis and their value in assessment of prognosis].
    Wang S; Chen D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):97-101. PubMed ID: 25665606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.